Nature:NK细胞使肿瘤进入休眠状态

2021-06-03 MedSci原创 MedSci原创

自然杀伤细胞可以驱使扩散的癌细胞进入休眠状态。这一发现,以及阻碍这种抗肿瘤功能的途径的发现,可能会刺激新疗法的发展。

转移瘤是癌症相关死亡的主要原因,转移瘤的治疗往往是失败的,因此找到控制它们的方法对于满足这一医疗需求至关重要。在转移开始生长之前,癌细胞可能已经从原发肿瘤转移到其他部位(这一过程称为转移),在那里它们可以长时间处于休眠状态。已知免疫细胞的监视有助于维持这种休眠状态,但从休眠到转移生长的机制至今仍不清楚。Correia等人在《自然》杂志上报道了自然杀伤(NK)细胞在控制乳腺癌引起的肝转移中的关键作用。 NK细胞是免疫系统固有分支的一部分。它们可以杀死其他细胞并产生被称为细胞因子和趋化因子的可溶性信使分子来调节免疫反应。NK细胞能够直接检测和消除多种肿瘤细胞,并通过制造细胞因子或趋化因子形成抗肿瘤免疫反应,这导致了利用其抗癌功能的临床策略的发展。 一些研究表明,NK细胞专门清除转移瘤,而不是以肿瘤细胞原发生长部位为目标。对于某些癌症来说,具有更多肿瘤浸润性NK细胞的人似乎转移更少,就像那些患有胃肠道肉瘤、胃癌、结肠直肠癌、肾癌或前列腺癌的人一样。小鼠NK细胞的缺失或功能障碍也会导致转移的增加。相比之下,当NK细胞的正常调节被移除时,它们可以保护肿瘤不扩散到肝脏和肺部。进入休眠状态的肿瘤细胞

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1218174, encodeId=5b9612181e47b, content=<a href='/topic/show?id=8dcd12852f1' target=_blank style='color:#2F92EE;'>#NK细胞#</a><a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12852, encryptionId=8dcd12852f1, topicName=NK细胞), TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 13:09:13 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010740, encodeId=65821010e40f7, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef462442681, createdName=医生说, createdTime=Mon Aug 23 21:26:16 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885201, encodeId=ecbc1885201b5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 16 12:02:20 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668072, encodeId=3d7816680e21b, content=<a href='/topic/show?id=902125e1351' target=_blank style='color:#2F92EE;'>#休眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25713, encryptionId=902125e1351, topicName=休眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e226239625, createdName=yese, createdTime=Mon Jun 21 19:02:20 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970531, encodeId=b3a29e0531d9, content=积分太少,努力挣积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/361bc9a5bc1a4a5da51bd6c9f8ae379c/ddc597c3e09a4d96b148c12d3abb921d.jpg, createdBy=5cbd5167579, createdName=146cd134m57(暂无昵称), createdTime=Thu Jun 03 10:46:15 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970506, encodeId=0ae59e050602, content=很棒,很棒的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e75409349, createdName=ms4000000871644201, createdTime=Thu Jun 03 08:39:20 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1218174, encodeId=5b9612181e47b, content=<a href='/topic/show?id=8dcd12852f1' target=_blank style='color:#2F92EE;'>#NK细胞#</a><a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12852, encryptionId=8dcd12852f1, topicName=NK细胞), TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 13:09:13 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010740, encodeId=65821010e40f7, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef462442681, createdName=医生说, createdTime=Mon Aug 23 21:26:16 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885201, encodeId=ecbc1885201b5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 16 12:02:20 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668072, encodeId=3d7816680e21b, content=<a href='/topic/show?id=902125e1351' target=_blank style='color:#2F92EE;'>#休眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25713, encryptionId=902125e1351, topicName=休眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e226239625, createdName=yese, createdTime=Mon Jun 21 19:02:20 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970531, encodeId=b3a29e0531d9, content=积分太少,努力挣积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/361bc9a5bc1a4a5da51bd6c9f8ae379c/ddc597c3e09a4d96b148c12d3abb921d.jpg, createdBy=5cbd5167579, createdName=146cd134m57(暂无昵称), createdTime=Thu Jun 03 10:46:15 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970506, encodeId=0ae59e050602, content=很棒,很棒的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e75409349, createdName=ms4000000871644201, createdTime=Thu Jun 03 08:39:20 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
    2021-08-23 医生说

    非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1218174, encodeId=5b9612181e47b, content=<a href='/topic/show?id=8dcd12852f1' target=_blank style='color:#2F92EE;'>#NK细胞#</a><a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12852, encryptionId=8dcd12852f1, topicName=NK细胞), TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 13:09:13 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010740, encodeId=65821010e40f7, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef462442681, createdName=医生说, createdTime=Mon Aug 23 21:26:16 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885201, encodeId=ecbc1885201b5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 16 12:02:20 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668072, encodeId=3d7816680e21b, content=<a href='/topic/show?id=902125e1351' target=_blank style='color:#2F92EE;'>#休眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25713, encryptionId=902125e1351, topicName=休眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e226239625, createdName=yese, createdTime=Mon Jun 21 19:02:20 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970531, encodeId=b3a29e0531d9, content=积分太少,努力挣积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/361bc9a5bc1a4a5da51bd6c9f8ae379c/ddc597c3e09a4d96b148c12d3abb921d.jpg, createdBy=5cbd5167579, createdName=146cd134m57(暂无昵称), createdTime=Thu Jun 03 10:46:15 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970506, encodeId=0ae59e050602, content=很棒,很棒的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e75409349, createdName=ms4000000871644201, createdTime=Thu Jun 03 08:39:20 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
    2021-11-16 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=1218174, encodeId=5b9612181e47b, content=<a href='/topic/show?id=8dcd12852f1' target=_blank style='color:#2F92EE;'>#NK细胞#</a><a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12852, encryptionId=8dcd12852f1, topicName=NK细胞), TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 13:09:13 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010740, encodeId=65821010e40f7, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef462442681, createdName=医生说, createdTime=Mon Aug 23 21:26:16 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885201, encodeId=ecbc1885201b5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 16 12:02:20 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668072, encodeId=3d7816680e21b, content=<a href='/topic/show?id=902125e1351' target=_blank style='color:#2F92EE;'>#休眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25713, encryptionId=902125e1351, topicName=休眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e226239625, createdName=yese, createdTime=Mon Jun 21 19:02:20 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970531, encodeId=b3a29e0531d9, content=积分太少,努力挣积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/361bc9a5bc1a4a5da51bd6c9f8ae379c/ddc597c3e09a4d96b148c12d3abb921d.jpg, createdBy=5cbd5167579, createdName=146cd134m57(暂无昵称), createdTime=Thu Jun 03 10:46:15 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970506, encodeId=0ae59e050602, content=很棒,很棒的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e75409349, createdName=ms4000000871644201, createdTime=Thu Jun 03 08:39:20 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
    2021-06-21 yese
  5. [GetPortalCommentsPageByObjectIdResponse(id=1218174, encodeId=5b9612181e47b, content=<a href='/topic/show?id=8dcd12852f1' target=_blank style='color:#2F92EE;'>#NK细胞#</a><a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12852, encryptionId=8dcd12852f1, topicName=NK细胞), TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 13:09:13 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010740, encodeId=65821010e40f7, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef462442681, createdName=医生说, createdTime=Mon Aug 23 21:26:16 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885201, encodeId=ecbc1885201b5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 16 12:02:20 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668072, encodeId=3d7816680e21b, content=<a href='/topic/show?id=902125e1351' target=_blank style='color:#2F92EE;'>#休眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25713, encryptionId=902125e1351, topicName=休眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e226239625, createdName=yese, createdTime=Mon Jun 21 19:02:20 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970531, encodeId=b3a29e0531d9, content=积分太少,努力挣积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/361bc9a5bc1a4a5da51bd6c9f8ae379c/ddc597c3e09a4d96b148c12d3abb921d.jpg, createdBy=5cbd5167579, createdName=146cd134m57(暂无昵称), createdTime=Thu Jun 03 10:46:15 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970506, encodeId=0ae59e050602, content=很棒,很棒的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e75409349, createdName=ms4000000871644201, createdTime=Thu Jun 03 08:39:20 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
    2021-06-03 146cd134m57(暂无昵称)

    积分太少,努力挣积分

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1218174, encodeId=5b9612181e47b, content=<a href='/topic/show?id=8dcd12852f1' target=_blank style='color:#2F92EE;'>#NK细胞#</a><a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12852, encryptionId=8dcd12852f1, topicName=NK细胞), TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 13:09:13 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010740, encodeId=65821010e40f7, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef462442681, createdName=医生说, createdTime=Mon Aug 23 21:26:16 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885201, encodeId=ecbc1885201b5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 16 12:02:20 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668072, encodeId=3d7816680e21b, content=<a href='/topic/show?id=902125e1351' target=_blank style='color:#2F92EE;'>#休眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25713, encryptionId=902125e1351, topicName=休眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e226239625, createdName=yese, createdTime=Mon Jun 21 19:02:20 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970531, encodeId=b3a29e0531d9, content=积分太少,努力挣积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/361bc9a5bc1a4a5da51bd6c9f8ae379c/ddc597c3e09a4d96b148c12d3abb921d.jpg, createdBy=5cbd5167579, createdName=146cd134m57(暂无昵称), createdTime=Thu Jun 03 10:46:15 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970506, encodeId=0ae59e050602, content=很棒,很棒的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e75409349, createdName=ms4000000871644201, createdTime=Thu Jun 03 08:39:20 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
    2021-06-03 ms4000000871644201

    很棒,很棒的文章

    0

相关资讯

Blood:脂质代谢增强介导了NK细胞在淋巴瘤中的功能受损

NK细胞在血液恶性肿瘤中具有重要的保护作用,但NK细胞可以获得一种功能失调的状态,在该状态下,其抗肿瘤免疫活性受限。但迄今为止,NK细胞这种功能受损的潜在原因仍未明确。

JCI:NK细胞助力PD-1用于NSCLC,效果倍增

由广东省蛋白质组学重点实验室姜勇教授团队开展的这项最新研究,惊讶地发现,PD-1抑制剂在临床治疗中对非小细胞肺癌具有活性,

Celularity异体NK细胞治疗新冠完成首例患者给药

近日,新基衍生公司Celularity宣布,其在研COVID-19自然杀伤(NK)细胞疗法CYNK-001的Ⅰ/Ⅱ期临床试验在加州大学尔湾分校完成了首例患者给药。

Nature子刊:NK细胞作为肿瘤免疫治疗平台的探索

NK细胞是一种可产生促炎细胞因子的先天淋巴样细胞,能够杀死被病毒感染的细胞或癌细胞。大约20年前,在晚期白血病患者中,NK细胞介导的免疫疗法已成为一种安全有效的疗法。在那之后,有关NK细胞的抗癌研究呈

Blood:转录因子ETS1调控NK细胞发育和终末分化

人ETS1缺乏会抑制几种NK细胞相关关键转录因子的表达和NK细胞的分化。 ETS1对于肿瘤细胞诱导性NK细胞毒性和IFN-γ的产生必不可少。

NK细胞接合剂(TriKE™)治疗乳腺癌和胃肠道癌症

GT Biopharma今天宣布,已提交美国和国际专利申请,并启动NK细胞接合剂(TriKE™)的临床开发,以治疗HER2+、HER3+和HER2+ / HER3+乳腺癌和胃肠道癌。